OakChart

ENDRA Life Sciences Inc

NDRAHealthcare·Diagnostics & Research·USA·Nano·NASD·Nov 11 • 3:59 PM ET

4.77-0.00 (-0.03%)
2026-11-12 02:29 CET
Market cap
7.15 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-5.92 USD m
Free cash flow, TTM
-4.84 USD m
EPS diluted, TTM
-6.32
P/E
-
Compare

Price

NDRA against its 20, 50 and 200-day averages
2050200earnings
4.005.006.00242K483KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NDRAclose 4.7720-day 4.8150-day 5.41200-day 4.824.77

31.4% under the 52-week high of 6.95 on 17 Nov 2025. 52-week low 2.96 on 10 Mar 2026. Last 15 sessions, 29.6% high to low

Volume 0.19× normal · the line is the 50-bar volume average

Profile

NDRA
52-week range, 45% of the way up
2.966.95

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Employees11
IPOJun 30, 2017
Beta-0.12
ATR, 14d0.37
Rel volume0.19
Short float3.28%
Insider own52.62%
Inst own10.39%

Snapshot

6 groups

Valuation

Index-
Market Cap7.15M
Enterprise Value2.04M
Income-5.92M
Sales0.00M
Book/sh4.21
Cash/sh3.70
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees11
IPOJun 30, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B1.13
P/C1.29
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio7.10
Current Ratio7.10
Debt/Eq0.07
LT Debt/Eq0.05
Option/ShortNo / Yes

Earnings

EPS (ttm)-6.32
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y89.62% 79.05%
Sales past 3/5Y- -
EPS Y/Y TTM98.17%
Sales Y/Y TTM-
EPS Q/Q107.07%
Sales Q/Q-
EarningsAug 17 BMO
EPS/Sales Surpr.11.38% -

Ownership

Insider Own52.62%
Insider Trans0.00%
Inst Own10.39%
Inst Trans3.73%
ROA-110.08%
ROE-152.04%
ROIC-89.64%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-0.84%
SMA50-11.87%
SMA200-1.02%
Trades-

Technical

Shs Outstand1.50M
Shs Float0.71M
Short Float3.28%
Short Ratio0.78
Short Interest0.02M
52W High6.95 -31.38%
52W Low2.96 61.11%
Volatility9.25% 7.36%
ATR (14)0.37
RSI (14)43.78
Beta-0.12
Rel Volume0.19
Avg Volume29.78K
Volume5,516

Performance

Perf Week-3.47%
Perf Month-5.38%
Perf Quarter6.68%
Perf Half Y-15.75%
Perf YTD5.27%
Perf Year-12.50%
Perf 3Y-99.71%
Perf 5Y-99.99%
Perf 10Y-
Recom1.00
Target Price25.00
Prev Close4.77
Price4.77
Change %-0.03%

Peers

Mkt cap
TickerCompanyMkt cap
BFLYButterfly Network Inc1.91B
HYPRHyperfine Inc75.43M
NNOXNano X Imaging Ltd28.66M
GEHCGE HealthCare Technologies Inc37.35B
PROFProfound Medical Corp287.55M
SRTSSensus Healthcare Inc56.13M
CLPTClearPoint Neuro Inc293.94M
POCIPrecision Optics Corp Inc55.41M
LUCDLucid Diagnostics Inc77.52M
ASPIASP Isotopes Inc300.48M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Anthony DiGiandomenicoBoard MemberJun 26 '26Proposed Sale6.0070,822425,000Jun 25 06:24 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-17-0.840-0.840-1.0900.000.001
2026Q12026-05-18-1.090-1.230-1.0900.000.001
2025Q42026-03-31-3.260-1.230-3.2490.000.001
2025Q32025-11-17-2.100-1.950-2.0970.000.001
2025Q22025-08-14-1.710-2.270-1.7100.000.001
2025Q12025-05-15-1.860-3.910-1.8590.000.001
2024Q42025-03-31-47.060-4.100-7.7280.000.001
2024Q32024-11-15-9.540-62.300-333.820.000.001
2024Q22024-08-22-140-122.5-142.980.000.001
2024Q12024-05-14-455-472.5-449.580.000.001
2023Q42024-03-28-297.5-630-245.820.000.001
2023Q32023-11-14-700-752.5-706.20.000.001
2023Q22023-08-14-752.5-962.5-746.310.000.001
2023Q12023-05-15-1,628-1,829-1,6250.000.002
2022Q42023-03-14-1,820-1,575-1,8170.000.702
2022Q32022-11-14-1,750-1,925-1,9060.000.002

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY-75,950--76,1110.00-
2019FY-81,900-43,050-81,7870.000.00
2020FY-22,050-25,200-22,1050.000.00
2021FY-9,800-9,800-9,7090.000.23
2022FY-7,980-7,700-7,9770.000.70
2023FY-2,765-3,238-2,7670.000.00
2024FY-56.940-47.460-56.9400.000.00
2025FY-8.930-6.590-8.9300.000.00
2026FY--3.540--0.00
2027FY--3.040--0.20

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-08-171000.000.000.00
2026Q3S2026-05-181000.000.000.00
2026Q3S2026-04-021000.000.000.00
2026Q3S2026-02-181000.000.000.00
2026Q3S2025-12-051010.000.000.00
2026Q3S2025-11-171000.100.100.10
2026Q3S2025-09-121000.100.100.10
2026Q3S2025-09-111000.100.100.10
2026Q3S2025-09-101000.100.100.10
2026Q3S2025-09-091000.100.100.10
2026Q3S2025-09-081000.100.100.10
2026Q3S2025-09-071000.100.100.10
2026Q3S2025-09-061000.100.100.10
2026Q3S2025-09-051000.100.100.10

Estimate history

EPS, annual-68250-76110.65-81786.95-22104.6-9709.35-7976.85-2766.523-56.94-8.929-6.3177
Period201720182019202020212022202320242025TTM
EPS, quarterly-142.975-333.824-7.728-1.859-1.71-2.097-3.249-1.0930.121
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.3520.00600000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0000.0010.0010.0020.0060.5371.1761.5
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.0410.0150.5370.5620.7520.7871.1761.2411.5
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.01
Cost of Goods Sold Incl. D&A0.160.160.210.280.230.220.170.120.07
Gross Profit-0.16-0.16-0.21-0.28-0.23-0.22-0.17-0.12-0.06
Selling, General and Administrative Excl. Other6.495.6110.6110.2512.9211.2711.3410.738.67
Research and Development1.951.853.195.006.555.485.926.574.72
Other Operating Expense0.000.007.320.000.000.000.000.000.00
Operating Income-6.65-5.76-18.14-10.52-13.16-11.50-11.50-10.84-8.73
Interest Expense0.000.00----0.232.360.00
Unusual Expense-0.351.66-3.080.000.00-0.310.00-0.29
Net Income Before Taxes-5.92-7.03-11.51-10.06-13.18-11.23-11.73-13.31-9.80
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-5.92-7.03-11.51-10.06-13.18-11.23-11.73-13.31-9.80
Net Income From Continuing Operations-5.92-7.03-11.51-10.06-13.18-11.23-11.73-13.31-9.80
Net Income-5.92-7.03-11.51-10.06-13.18-11.35-12.12-17.53-9.80
EPS (Recurring)-4.66-7.45-67.60-2,766.52-7,976.85-9,894.06-22,104.62-81,786.97-74,546.91
EPS (Basic, Before Extraordinaries)-6.32-8.93-56.94-2,766.52-7,976.85-9,709.35-22,104.60-81,786.95-76,110.65
EPS (Diluted)-6.32-8.93-56.94-2,766.52-7,976.85-9,709.35-22,104.60-81,786.95-76,110.65
EBITDA-6.49-5.61-17.93-10.25-12.92-11.27-11.34-10.73-8.66
Non-Operating Income (Expense)0.380.403.560.46-0.02-0.040.01-0.11-0.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.980.330.491.001.200.500.81--
Price To Sales Ratio--------1,094.48
Gross Margin---------1,006.51
Operating Margin---------141,423.18
Net Margin---------158,669.60
Shares Outstanding1.501.180.540.010.000.000.000.000.00
Market Capitalization7.157.153.3617.8312.8629.4425.5414.1511.13

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.040.040.040.040.030.050.050.05
Gross Profit-0.04-0.04-0.04-0.04-0.03-0.05-0.05-0.05
Selling, General and Administrative Excl. Other1.442.131.581.331.271.424.251.46
Research and Development0.230.780.510.430.380.530.640.79
Other Operating Expense0.000.000.000.000.000.000.007.32
Operating Income-1.48-2.17-1.62-1.37-1.30-1.47-4.30-8.83
Interest Expense0.000.000.000.000.000.00--
Unusual Expense-1.63-0.851.860.27-0.06-0.410.27-3.34
Net Income Before Taxes0.16-1.31-3.17-1.60-1.23-1.04-4.15-2.35
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income0.16-1.31-3.17-1.60-1.23-1.04-4.15-2.35
Net Income From Continuing Operations0.16-1.31-3.17-1.60-1.23-1.04-4.15-2.35
Net Income0.16-1.31-3.17-1.60-1.23-1.04-4.15-2.35
EPS (Recurring)-0.74-1.59-1.91-1.85-1.77-2.37-7.38-665.55
EPS (Basic, Before Extraordinaries)0.12-1.09-3.25-2.10-1.71-1.86-7.73-333.82
EPS (Diluted)0.12-1.09-3.25-2.10-1.71-1.86-7.73-333.82
EBITDA-1.44-2.13-1.58-1.33-1.27-1.42-4.25-8.78
Non-Operating Income (Expense)0.010.010.320.040.010.020.413.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.230.570.030.150.070.080.40-0.14
Shares Outstanding1.501.241.180.790.750.560.540.02
Market Capitalization7.155.425.284.052.592.203.360.11

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments0.763.232.834.899.467.236.176.475.60
Short Term Receivables0.000.000.000.000.000.000.000.000.01
Inventories0.000.000.002.641.280.590.110.060.19
Other Current Assets0.210.200.200.991.350.400.250.420.08
Total Current Assets0.973.433.038.5312.098.216.546.955.88
Net Property, Plant & Equipment0.500.650.470.740.770.550.640.270.24
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets-----0.000.000.000.00
Other Assets2.380.373.260.010.010.000.000.000.00
Total Assets3.854.456.759.2712.878.767.187.226.12
Short Term Debt Incl. Current Port. of LT Debt0.130.100.200.180.130.080.360.000.00
Accounts Payable0.380.270.360.610.790.401.280.630.78
Other Current Liabilities0.240.240.340.910.620.510.430.340.07
Total Current Liabilities0.750.610.901.701.540.992.070.970.85
Long Term Debt0.360.490.190.370.550.610.340.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.480.800.000.000.000.000.000.000.00
Total Liabilities1.591.891.102.072.091.602.420.970.85
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.001E-061E-061E-061E-061E-060.000.00
Common Equity2.262.565.667.2010.787.174.766.255.28
Total Shareholders Equity2.262.565.667.2010.787.174.766.255.28
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity2.262.565.667.2010.787.174.766.255.28
Total Liabilities & Stockholders Equity3.854.456.759.2712.878.767.187.226.12
Book Value Per Share1.924.77953.143,978.388,869.777,369.4119,785.7129,462.1947,066.23
Tangible Book Value Per Share1.924.77953.143,978.388,869.777,369.4119,785.7129,462.1947,066.23
Full-Time Employees112121212218151113
Price to Book Ratio1.130.013.431.262.733.562.971.782.65
Return on Assets-169.21-205.38-125.53-119.01-103.80-147.11-184.82-146.80-162.58
Return on Equity-291.56-280.02-156.42-146.53-125.11-196.57-241.73-170.02-245.43
Return on Invested Capital-267.91-377.58-171.94-174.09-99.12-150.75-260.72-156.79-101.92
Quick Ratio1.295.673.363.457.007.733.107.076.71
Current Ratio1.295.673.365.007.838.323.157.136.93

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-5.92-7.03-11.51-10.06-13.18-11.23-11.73-13.31-9.80
Depreciation0.160.160.210.280.230.220.170.120.07
Other Funds (Non Cash)0.501.663.771.161.201.152.334.002.38
Funds from Operations-5.26-5.21-7.53-8.63-11.74-9.86-9.23-9.19-7.34
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.430.020.13-0.92-1.03-1.26-1.520.60-0.36
Cash from Operating Activities-4.82-5.18-7.40-9.55-12.77-11.12-10.75-8.59-7.70
Capital Expenditures-3.02-3.02-0.02-0.03-0.20-0.04-0.08-0.04-0.10
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.010.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources2.690.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.33-3.02-0.01-0.02-0.20-0.04-0.08-0.04-0.10
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock8.895.737.847.528.4013.4011.545.847.74
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock8.895.737.847.528.4013.4011.545.847.74
Proceedsfrom Stock Options8.895.731.156.488.4010.626.785.847.74
Issuance or Reduction of Debt, Net0.000.00-0.030.000.000.000.342.490.94
Change in Long Term Debt0.000.00-0.030.000.000.000.340.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.340.000.00
Reduction of Long Term Debt0.000.00-0.030.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities8.895.737.817.528.4013.4011.888.348.67
Net Change in Cash3.73-2.470.40-2.06-4.572.231.05-0.300.87
Free Cash Flow-4.84-5.20-7.42-9.58-12.97-11.17-10.82-8.63-7.80
Preferred Dividends (Cash Flow)-0.000.00-----0.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments5.540.360.760.791.812.06
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets0.050.180.210.250.040.12
Total Current Assets5.590.540.971.051.852.18
Net Property, Plant & Equipment0.440.460.500.540.580.62
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.902.43----
Other Assets0.010.012.380.370.370.37
Total Assets7.943.443.851.962.813.17
Short Term Debt Incl. Current Port. of LT Debt0.140.130.130.130.130.13
Accounts Payable0.460.460.380.250.280.22
Other Current Liabilities0.180.240.240.420.170.22
Total Current Liabilities0.790.840.750.800.580.57
Long Term Debt0.290.330.360.400.430.46
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.560.490.480.600.330.39
Total Liabilities1.631.651.591.791.331.42
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity6.311.792.260.171.471.75
Total Shareholders Equity6.311.792.260.171.471.75
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity6.311.792.260.171.471.75
Total Liabilities & Stockholders Equity7.943.443.851.962.813.17
Book Value Per Share4.211.441.920.221.963.12
Tangible Book Value Per Share2.94-0.521.920.221.963.12
Full-Time Employees--11---
Price to Book Ratio1.132.4220.802.751.130.86
Return on Assets-110.08-220.99-169.21-154.83-132.30-237.35
Return on Equity-152.04-412.60-291.56-236.34-167.48-358.41
Return on Invested Capital2.42-62.03-120.82-281.02-64.44-46.81
Quick Ratio7.100.641.291.313.213.85
Current Ratio7.100.641.291.313.213.85

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income0.16-1.31-3.17-1.60-1.23-1.04
Depreciation0.040.040.040.040.030.05
Other Funds (Non Cash)-1.17-0.291.550.410.03-0.33
Funds from Operations-0.98-1.56-1.58-1.14-1.17-1.32
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.050.44-0.03-0.020.050.02
Cash from Operating Activities-0.93-1.12-1.61-1.16-1.11-1.29
Capital Expenditures-0.020.00-3.000.000.00-0.02
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources2.240.450.000.000.000.00
Cash from Investing Activities2.220.45-3.000.000.00-0.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.890.264.580.150.860.15
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.890.264.580.150.860.15
Proceedsfrom Stock Options3.890.264.580.150.860.15
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities3.890.264.580.150.860.15
Net Change in Cash5.18-0.41-0.03-1.01-0.26-1.16
Free Cash Flow-0.95-1.12-1.61-1.16-1.11-1.31

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.28%0.0M0.7M31.00K
2026-10-153.39%0.0M0.7M32.24K
2026-09-302.94%0.0M1.0M35.74K
2026-09-153.26%0.0M1.0M40.71K
2026-08-313.29%0.0M1.0M30.23K
2026-08-143.46%0.0M0.9M31.77K
2026-07-314.51%0.0M0.7M31.03K
2026-07-153.79%0.0M0.7M31.73K
2026-06-305.77%0.0M0.7M28.07K
2026-06-153.27%0.0M0.7M23.31K
2026-05-293.00%0.0M0.7M35.74K
2026-05-154.94%0.0M0.7M107.03K
2026-04-306.06%0.0M0.6M110.08K
2026-04-157.43%0.0M0.7M113.20K
2026-03-318.11%0.1M0.7M112.87K
2026-03-138.84%0.1M0.6M107.34K
2026-02-2725.37%0.2M0.6M115.12K
2026-02-139.63%0.1M0.6M53.27K
2026-01-307.58%0.0M0.6M56.65K
2026-01-155.49%0.0M0.9M73.01K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-06425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-11-05425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-26425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-083Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-08SCHEDULE 13DSEC
2026-10-02S-4Registration statement for securities to be issued in business combination transactionsSEC
2026-10-01425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-018-KCurrent report2026-10-01SEC
2026-09-25425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-14425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-21425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-20425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-17425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-178-KCurrent report2026-08-17SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-06425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-05425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-04425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-22425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-22425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-17425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-098-KCurrent report2026-07-08SEC
2026-06-29SCHEDULE 13D/ASEC
2026-06-26425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-06-268-KCurrent report2026-06-25SEC
2026-06-25425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-06-25144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Altium Capital Management LLC3.64%
CITADEL ADVISORS LLC2.36%
CITIZENS FINANCIAL GROUP INC/RI1.89%
GEODE CAPITAL MANAGEMENT, LLC0.99%
VANGUARD FIDUCIARY TRUST CO0.80%
VANGUARD CAPITAL MANAGEMENT LLC0.58%
UBS Group AG0.40%
MORGAN STANLEY0.28%
CITIGROUP INC0.07%
Tower Research Capital LLC0.00%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.58%
Fidelity Extended Market Index Fund0.44%
Fidelity Nasdaq Composite Index Fund0.20%
Fidelity Series Total Market Index Fund0.11%

OakChart. NDRA. Cached 15 minutes.

Some panels did not load: ratings.